Edition:
United Kingdom

IDEXX Laboratories Inc (IDXX.OQ)

IDXX.OQ on NASDAQ Stock Exchange Global Select Market

225.79USD
16 Oct 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$225.79
Open
$219.30
Day's High
$226.24
Day's Low
$219.30
Volume
131,424
Avg. Vol
173,561
52-wk High
$256.22
52-wk Low
$146.19

Latest Key Developments (Source: Significant Developments)

Idexx Laboratories Reports Q2 Earnings Per Share Of $1.23
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - IDEXX Laboratories Inc ::IDEXX LABORATORIES ANNOUNCES SECOND QUARTER RESULTS.Q2 REVENUE $581 MILLION VERSUS I/B/E/S VIEW $574.6 MILLION.SEES FY 2018 EARNINGS PER SHARE $4.10 TO $4.20.Q2 EARNINGS PER SHARE $1.23.SEES FY 2018 REVENUE $2.205 BILLION TO $2.23 BILLION.SEES FY 2018 REVENUE UP 12 TO 13.5 PERCENT.Q2 EARNINGS PER SHARE VIEW $1.17 -- THOMSON REUTERS I/B/E/S.IDEXX LABORATORIES - 2018 REVENUE OUTLOOK INCORPORATES NEGATIVE IMPACT OF $20 MILLION - $25 MILLION RELATED TO UPDATED FOREIGN EXCHANGE ASSUMPTIONS.IDEXX LABORATORIES - ESTIMATE WEAKER U.S. DOLLAR WILL BENEFIT 2018 REPORTED REVENUE GROWTH BY ABOUT 0.5% - 1% & EPS BY AN ESTIMATED $0.01 PER SHARE.IDEXX LABORATORIES - SEES 2018 CAPEX OF ABOUT $140 MILLION.  Full Article

IDEXX Laboratories says Reduced Board Size To Eight
Tuesday, 15 May 2018 

May 15 (Reuters) - IDEXX Laboratories Inc ::IDEXX LABORATORIES - REDUCED BOARD SIZE TO EIGHT & SIZE OF CLASS I TO TWO MEMBERS, EFFECTIVE UPON WILLIAM END'S RETIREMENT FROM BOARD - SEC FILING.  Full Article

Idexx Laboratories Announces Estimated Impact Of U.S. Tax Reform
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Idexx Laboratories Inc ::IDEXX LABORATORIES ANNOUNCES ESTIMATED IMPACT OF U.S. TAX REFORM.IDEXX LABORATORIES - ‍EXPECTS TAX CUTS AND JOBS ACT TO BENEFIT CO BY REDUCING RECURRING EFFECTIVE TAX RATE BEGINNING 2018 BY ABOUT 750-850 BPS.IDEXX LABORATORIES - SEES TAX LEGISLATION ENACTMENT TO RESULT IN ONE-TIME REDUCTION ABOUT $35 MILLION - $45 MILLION IN EARNINGS FOR Q4,YEAR ENDED DEC 31, 2017.  Full Article

IDEXX Laboratories Q3 earnings per share $0.79
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - IDEXX Laboratories Inc :IDEXX Laboratories announces third quarter results.Q3 revenue $492 million versus I/B/E/S view $493.1 million.Sees FY 2018 earnings per share $3.50 to $3.62.Raises FY 2017 earnings per share view to $3.22 to $3.26.Sees FY 2018 revenue up 9.5 to 11.5 percent.Sees FY 2017 revenue $1.95 billion to $1.96 billion.Q3 earnings per share $0.79.Q3 earnings per share view $0.74 -- Thomson Reuters I/B/E/S.FY2018 earnings per share view $3.54 -- Thomson Reuters I/B/E/S.  Full Article

Idexx Labs director End sells 5,000 shares of co's common stock on May 22
Tuesday, 23 May 2017 

May 23 (Reuters) - Idexx Laboratories Inc :Idexx Laboratories director William End reports sale of 5,000 shares of co's common stock on May 22 at average price of $162.55 per share - SEC filing.  Full Article